Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abnoba Korea is a specialized pharmaceutical company based in South Korea that focuses on integrative oncology and the distribution of mistletoe-based cancer therapies. The company serves as the exclusive partner of the German firm Abnoba GmbH, bringing the AbnobaVISCUM product line to the Korean market. AbnobaVISCUM is a biologic extract derived from mistletoe plants, utilized as a supportive treatment to stimulate the immune system and improve the quality of life for cancer patients. The company offers various formulations based on the host tree of the mistletoe, including Fraxini, Quercus, and Mali, allowing for personalized treatment protocols. Abnoba Korea is a prominent player in the Korean complementary medicine sector, providing extensive clinical data and education on mistletoe therapy to healthcare professionals. Their business model emphasizes evidence-based integrative medicine to support patients undergoing conventional chemotherapy and radiation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abnoba Korea.